Chimeric West Nile/dengue virus vaccine candidate: Preclinical evaluation in mice, geese and monkeys for safety and immunogenicity

This publication has 31 references indexed in Scilit:

• Recent advances in the molecular biology of west nile virus.
  Current Molecular Medicine, 2005
• Epidemiology and Transmission Dynamics of West Nile Virus Disease
  Emerging Infectious Diseases, 2005
• Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus
  Journal of Virology, 2005
• ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy
  Journal of Virology, 2004
• West Nile virus vaccines
  Expert Opinion on Biological Therapy, 2004
• Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus
  Virology, 2003
• West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy
  Proceedings of the National Academy of Sciences, 2002
• Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
  The American Journal of Tropical Medicine and Hygiene, 2001
• Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes
  Journal of Virology, 2001
• Infectious cDNA Clone of Attenuated Langat Tick-Borne Flavivirus (Strain E5) and a 3′ Deletion Mutant Constructed from It Exhibit Decreased Neuroinvasiveness in Immunodeficient Mice
  Virology, 2001